INS and fetal growth restriction: This finding aligns with previous studies that associate prematurity and intrauterine growth restriction with altered glucose homeostasis, potentially driven by immature insulin secretion, exaggerated stress responses, and the frequent use of parenteral nutrition in this population (Inage et al., 2022; Beardsall, 2021).